期刊文献+

杂环并五环三萜化合物的合成及糖原磷酸化酶抑制活性 被引量:3

Synthesis and biological activity of heterocycle-fused derivatives of pentacylic triterpenes as glycogen phosphorylase inhibitors
下载PDF
导出
摘要 目的:对天然五环三萜进行结构修饰,寻找新型糖原代谢调控药物。方法:以齐墩果酸和熊果酸为先导物,在其A环骈合吲哚环、喹喔啉环和吡嗪环,合成一系列含氮杂环衍生物,并采用兔肌肉糖原磷酸化酶筛选模型评价其活性。结果与结论:合成了12个杂环衍生物,结构均经IR、1H NMR、13C NMR和MS确证。除化合物12外,其余化合物均显现出糖原磷酸化酶抑制活性,IC50在14~252μmol/L范围内。其中,化合物15活性最好,其IC50为14μmol/L。 Aim:To search for novel modulators of glycogen metabolism through structural modifications of natural pentacyclic triterpenes.Methods:A series of N-heterocyclic derivatives were synthesized by fusing indole,quinoxaline and pyrazine rings with A-ring of oleanolic and ursolic acids.The compounds were biologically evaluated for their inhibitory activity against rabbit muscle glycogen phosphorylase.Results and Conclusion:Twelve heterocyclic triterpene derivatives were synthesized and their structures were confi...
出处 《中国药科大学学报》 CAS CSCD 北大核心 2009年第6期491-496,共6页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目(No.30672523,No.90713037)~~
关键词 五环三萜 结构修饰 杂环化合物 糖原磷酸化酶抑制剂 pentacyclic triterpene structural modification heterocyclic compounds glycogen phosphorylase inhibitors
  • 相关文献

参考文献10

  • 1Myriad Pharmaceutical.Phase 2 safety and efficacy study of be-virimat functional monotherapy in HIV treatment-experienced pa-tient for 2 weeks. http://clinicaltri-als.gov/ct2/show/NCT00511368 . 2009
  • 2Reata Pharma-ceuticals,Inc.Clinical Trials. http://www.reatapharma.com/clinical_trials.asp . 2008
  • 3Atta-ur-Rahman,,Zareen S,Choudhary MI,et al.α-Glucosidaseinhibitory activity of triterpenoids fromCichorium intybus[].JNat Prod.2008
  • 4Wen XA,,Sun HB,Liu J,et al.Pentacyclic triterpenes.Part 1:The first examples of naturally occurring pentacyclic triterpenesas a new class of inhibitors of glycogen phosphorylases[].Bioorganic and Medicinal Chemistry.2005
  • 5Wen XA,,Sun HB,Liu J,et al.Naturally occurring pentacyclictriterpenes as inhibitors of glycogen phosphorylase:synthesis,structure-activity relationships,and X-ray crystallographic studies[].Journal of Medicinal Chemistry.2008
  • 6Hao J,,Zhang P,Wen XA,et al.Efficient access to2-isobetulinicacid,2-isooleanolic acid and 2-isoursolic acid[].JOrg Chem.2008
  • 7Zhang P,,Hao J,Liu J,et al.Efficient synthesis of morolic acidand related triterpenes starting from betulin[].Tetrahedron.2009
  • 8Wen XA,,Xia J,Cheng KG,et al.Pentacyclic triterpenes.Part5:Synthesis and SAR study of corosolic acid derivatives as inhibi-tors of glycogen phosphorylases[].Bioorganic and Medicinal Chemistry.2007
  • 9Cheng KG,,Zhang P,Liu J,et al.Practical synthesis of bredemol-ic acid,a natural inhibitor of glycogen phosphorylase[].Journal of Natural Products.2008
  • 10Martin WH,Hoover DJ,Armento SJ,et al.Discovery of a humanliver glycogen phosphorylase inhibitor that lowers blood glucosein vivo[].Proceedings of the National Academy of Sciences of the United States of America.1998

同被引文献35

  • 1孙宏斌.以糖代谢干预为基础的新药研究与开发[J].中国药科大学学报,2006,37(1):1-8. 被引量:11
  • 2陈军,柳军,龚彦春,张陆勇,华维一,孙宏斌.新型糖原磷酸化酶抑制剂熊果酸衍生物的合成及其生物活性[J].中国药科大学学报,2006,37(5):397-402. 被引量:19
  • 3Loughlin WA. Recent advances in the allosteric inhibition of gly- cogen phosphorylase [ J ]. Mini-Rev Med Chem, 2010,10 ( 12 ) : 1139 - 1155.
  • 4Treadway JL, Levy C B, Hoover D J, et al. Glucose lowering by glucose phosphorylase inhibition in rats, dogs and humans [ J ].Diabetes ,2001,50(2) :A133 - A133.
  • 5Treadway JL. Symposia on New Targets for Glycemic Control [ C ]//65th American Diabetes Association National Meeting. San Diezo ,2005.
  • 6Hayes JM, Leonidas DD. Computation as a tool for glycogen phos- phorylase inhibitor design mini-reviews in medicinal chemistry [ J ]. Mini-Rev Med Chem ,2010,10 (12) : 1156 - 1174.
  • 7Maha H ,Taha MO. Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads [Jl. Bioorg Med Chem,2011,19(16 ) :4746 -4771.
  • 8Oikonomakos NG. Glycogen phosphorylase as a molecular target for type 2 diabetes therapy [ J ]. Curr Protein Pept Sci, 2002,3 (6) :561 -586.
  • 9Wen XA, Zhang P, Liu J, et al. Pentacyclic triterpnes. Part 2 : syn- thesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors [ J ] Bioorg Med Chem Lett, 2006,16 ( 3 ) :722 - 726.
  • 10Chen J, Liu J, Zhang LY, et al. Pentacyclic triterpenes. Part 3: synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase[ J]. Bioorg Med Chem Lett ,2006,16( 11 ) :2915 - 2919.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部